Impact of COVID-19 pandemic on physical and mental health status and care of adults with epilepsy in Germany

• Published in: Neurological research and practice Vol. 4; no. 1; p. 44
• Main Authors: Körbel, Kimberly, Rosenow, Felix, Maltseva, Margarita, Müller, Heiko, Schulz, Juliane, Tsalouchidou, Panagiota-Eleni, Langenbruch, Lisa, Kovac, Stjepana, Menzler, Katja, Hamacher, Mario, von Podewils, Felix, Willems, Laurent M, Mann, Catrin, Strzelczyk, Adam
• Format: Journal Article
• Language: English
• Published: Berlin Springer Nature B.V 22-09-2022; BioMed Central; BMC
• Subjects: Antiseizure medication; Clinical trials; Coronaviruses; COVID-19; Disease burden; Epilepsy; Health care; Mental health; Pandemics; Patients; SARS-CoV-2; Seizure; Seizures; Women; Germany
• ISSN: 2524-3489; 2524-3489
• DOI: 10.1186/s42466-022-00209-5

Abstract
Background
To mitigate the potential consequences of the coronavirus disease 2019 (COVID-19) pandemic on public life, the German Federal Government and Ministry of Health enacted a strict lockdown protocol on March 16, 2020. This study aimed to evaluate the impact of the COVID-19 pandemic on physical and mental health status and the supply of medical care and medications for people with epilepsy (PWE) in Germany.
Methods
The Epi2020 study was a large, multicenter study focused on different healthcare aspects of adults with epilepsy. In addition to clinical and demographic characteristics, patients were asked to answer a questionnaire on the impact of the first wave of the COVID-19 pandemic between March and May 2020. Furthermore, the population-based number of epilepsy-related admissions in Hessen was evaluated for the January-June periods of 2017–2020 to detect pandemic-related changes.
Results
During the first wave of the pandemic, 41.6% of PWE reported a negative impact on their mental health, while only a minority reported worsening of their seizure situation. Mental and physical health were significantly more negatively affected in women than men with epilepsy and in PWE without regular employment. Moreover, difficulties in ensuring the supply of sanitary products (25.8%) and antiseizure medications (ASMs; 19.9%) affected PWE during the first lockdown; no significant difference regarding these impacts between men and women or between people with and without employment was observed. The number of epilepsy-related admissions decreased significantly during the first wave.
Conclusions
This analysis provides an overview of the general and medical care of epilepsy patients during the COVID-19 pandemic. PWE in our cohort frequently reported psychosocial distress during the first wave of the pandemic, with significant adverse effects on mental and physical health. Women and people without permanent jobs especially reported distress due to the pandemic. The COVID‐19 pandemic has added to the mental health burden and barriers to accessing medication and medical services, as self-reported by patients and verified in population-based data on hospital admissions.
Trial registration
German Clinical Trials Register (DRKS), DRKS00022024. Registered October 2, 2020,
http://www.drks.de/DRKS00022024